FindOwnerSearch
Brands and Their Owners
| Brand | Owner (click to sort) | Address | Description |
|---|---|---|---|
| ATOMIC AI | ATOMATAI, INC. | 156 University Drive Menlo Park CA 94025 | pharmaceutical preparations for the modification of RNA expression and alteration of RNA translation for the treatment of cancers and autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders, blood disorders, bone growth disorders, skin disorders, arthritis, hypertension, pain, stroke, obesity and diabetes;AI;research and development of pharmaceuticals, namely, therapies for the modification of RNA expression and alteration of RNA translation, used in the treatment of cancers and autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders, blood disorders, bone growth disorders, skin disorders, arthritis, hypertension, pain, stroke, obesity and diabetes; research and development in the fields of biotechnology, DNA, RNA, molecules and proteins; automated design and development of biomolecules for medical and scientific use, for use in the manufacture of biosensors, agriculture, synthetic biological research, laboratories and environmental safety and testing; drug design and development featuring machine-learning algorithms and lab automation tools; developing customized software in the field of drug design and development; |
| MOGRAA | NB HEALTH LABORATORY CO. LTD. | North 21 West 12-2 kita-ku, Sapporo-shi Hokkaido 001-0021 Japan | Pharmaceutical preparations for modification of the function of g-protein-coupled receptors, consisting of monoclonal antibody; pharmaceutical preparations for the treatment and prevention of obesity, diabetes, cardiovascular diseases, central nervous system diseases, metabolic disorders, stroke, cancer, inflammatory diseases, respiratory diseases, infectious diseases, auto-immune diseases and pain; antibodies for medical purposes; reagent paper for medical purposes;Scientific research; research and development services in the field of antibodies; research and development for the pharmaceutical industry; chemistry services; testing, inspection or research of pharmaceuticals, cosmetics or foodstuffs; design and development of computer software; consultancy relating to design and development of computer software; computer software design, computer programming, or maintenance of computer software; |
Where the owner name is not linked, that owner no longer owns the brand |